Navigation Links
Alexander Proudfoot Appoints Executive Vice President for Life Sciences

Atlanta, Georgia (PRWEB) July 19, 2013

Alexander Proudfoot Company ( announces the appointment of Richard Denness as Executive Vice President for its Life Sciences Practice. Denness, a recognised industry leader further strengthens the firm’s fast-growing practice.

Luiz Carvalho, Chief Executive Officer said “Richard’s wealth of experience and industry knowledge makes him a key addition to the Alexander Proudfoot family, as we look to further develop our offerings to companies across this important sector. Richard is a leading Life Sciences expert with over 24 years of in depth and wide ranging experience. I am confident his appointment will strengthen our ability to deliver significant improvements to companies throughout the sector.”

The Life Sciences sector is an industry in transformation. Following years of growth, companies now face a new era and one distinguished by a changing healthcare landscape, pricing pressures, heightened regulatory scrutiny, increasing alliances and acquisitions as well as expiring patents and increased competition from generics. Companies are under pressure to change—and quickly as they look to meet these challenges head on.

Over the past 67 years, Alexander Proudfoot has been partnering with numerous companies in the sector. However, the current industry challenges will require additional resources. As Executive Vice President for Alexander Proudfoot’s Life Sciences Practice, Denness will lead the firm’s efforts to enhance and expand the services offered to clients across the sector.

A graduate from Missouri State University, he understands the global environment and the challenges facing Life Sciences companies, having worked in Asia-Pacific, Europe, Canada, and the US. He has direct experience of driving revenue, building brands, and greatly improving profitability. He has held various executive leadership roles, including General Manager, Australia and New Zealand with Schering-Plough, President of IVAX Laboratories, Vice President, Managed Care at UCB, Vice President and General Manager of UCB’s Central Nervous System business unit, and CEO of Vycor Medical.

Richard Denness comments “I am excited to start a new challenge within Alexander Proudfoot and look forward to working with the team to further develop Life Sciences. I am fortunate to be joining such a respected company that prides itself on transforming business performance.”

Mr Denness will be based out of Alexander Proudfoot’s Atlanta headquarters.

About Alexander Proudfoot
Alexander Proudfoot is in the business of driving disciplined execution within its client’s organization, enabling it to measure and achieve its growth targets, revenue and profit goals with greater speed, predictability, and control. For over 65 years, Alexander Proudfoot has been the firm of choice for business executives seeking new and innovative ways to rapidly improve operational performance.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Alexander Fleming on Searching for Solutions to Metabesity and Healthy Aging
2. KemPharm, Inc. Appoints Gordon K. "Rusty" Johnson as Chief Operating Officer and Chief Financial Officer
3. KaloBios Appoints Donald R. Joseph as Chief Legal Officer
4. Organovo Appoints Tamar D. Howson to Board of Directors
5. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
6. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
7. SPIE Appoints Ni-Bin Chang Editor of Journal of Applied Remote Sensing
8. Envera Appoints Michael McErlean Fermentation Manager
9. WMIS Appoints Lisa Baird as Next Executive Director
10. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
11. Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) ... remaining 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) ... B Warrants") subject to the previously disclosed November ... 2015, which will result in the issuance of ... the issuance of such shares, there will be ...
(Date:11/24/2015)... ... November 24, 2015 , ... Creation Technologies ... being named to Deloitte's 2015 Technology Fast 500 list of the fastest growing ... a FDA-cleared, Class II medical device that speeds up orthodontic tooth movement by ...
Breaking Biology Technology:
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... 27, 2015 In the present market scenario, ... for various industry verticals such as banking, healthcare, defense, ... growing demand for secure & simplified access control and ... as hacking of bank accounts, misuse of users, , ... as PC,s, laptops, and smartphones are expected to provide ...
(Date:10/26/2015)... PALO ALTO, Calif. and LAS ... – Nok Nok Labs , an innovator in ... FIDO Alliance , today announced the launch of its ... the first unified platform enabling organizations to use standards-based ... authentication. The Nok Nok S3 Authentication Suite is ideal ...
Breaking Biology News(10 mins):